Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor

Published:2018-11-07 Issue:3 Volume:76 Page:561-576
ISSN:1420-682X
Container-title:Cellular and Molecular Life Sciences
language:en
Short-container-title:Cell. Mol. Life Sci.

Author:

Garcia Cédric,Maurel-Ribes Agnès,Nauze Michel,N’Guyen Du,Martinez Laurent O.,Payrastre Bernard,Sénard Jean-Michel,Galés Céline,Pons Véronique^ORCID

Funder

Fondation Bettencourt Schueller

Fondation pour la Recherche Médicale

Institut Universitaire de France

Institut National de la Santé et de la Recherche Médicale

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/article/10.1007/s00018-018-2960-3/fulltext.html

Reference54 articles.

1. Sabouret P, Rushton-Smith SK, Kerneis M, Silvain J, Collet JP, Montalescot G (2015) Dual antiplatelet therapy: optimal timing, management, and duration. Eur Heart J Cardiovasc Pharmacother 1:198–204

2. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V et al (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202–207

3. Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R et al (2010) Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56:919–933

4. Gurbel PA, Kereiakes DJ, Tantry US (2010) Ticagrelor for the treatment of arterial thrombosis. Expert Opin Pharmacother 11:2251–2259

5. Husted S, van Giezen JJ (2009) Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist. Cardiovasc Ther 27:259–274

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of the role of purinergic signaling and insights into its role in cancer therapy;Pharmacology & Therapeutics;2024-10

2. Progress on the development of Class A GPCR‐biased ligands;British Journal of Pharmacology;2024-09-11

3. MRGPRB2/X2 and the analogous effects of its agonist and antagonist in DSS-induced colitis in mice;Biomedicine & Pharmacotherapy;2024-05

4. Pharmacological characterization of P2Y receptor subtypes – an update;Purinergic Signalling;2023-09-12

5. Ticagrelor inverse agonist activity at the P2Y₁₂ receptor is non‐reversible versus its endogenous agonist adenosine 5´‐diphosphate;British Journal of Pharmacology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3